What is the value of medicines and innovation for the patient?

Anthony Mark Cutter, Natasha Burns, Julia Manning, Ginette Camps-Walsh and Sarah Wilson explain why there is a need for a system that can evaluate new interventions fairly and encourage medical companies to invest in more innovation and research while satisfying the individual needs of patients.

Access the full article in the Pharmaceutical Journal